The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Z Sondka, S Bamford, CG Cole, SA Ward… - Nature Reviews …, 2018 - nature.com
Abstract The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census
(CGC) is an expert-curated description of the genes driving human cancer that is used as a …

The nuclear export protein XPO1—from biology to targeted therapy

AS Azmi, MH Uddin, RM Mohammad - Nature reviews Clinical oncology, 2021 - nature.com
Abstract Exportin 1 (XPO1), also known as chromosome region maintenance protein 1,
plays a crucial role in maintaining cellular homeostasis via the regulated export of a range of …

[HTML][HTML] Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins

N Khodabandehlou, S Mostafaei, A Etemadi… - BMC cancer, 2019 - Springer
Background Breast cancer is currently the most common neoplasm diagnosed in women
globally. There is a growing body of evidence to suggest that human papillomavirus (HPV) …

HPV-associated cancers: insights into the mechanistic scenario and latest updates

AG Mukherjee, U Ramesh Wanjari… - Medical Oncology, 2023 - Springer
Cancer and related diseases are the second leading cause of death worldwide. The human
papillomavirus (HPV) is an infectious agent that can be spread mainly through sexual …

Overactive BRCA1 affects presenilin 1 in induced pluripotent stem cell-derived neurons in Alzheimer's disease

M Wezyk, A Szybinska, J Wojsiat… - Journal of …, 2018 - content.iospress.com
The BRCA1 protein, one of the major players responsible for DNA damage response has
recently been linked to Alzheimer's disease (AD). Using primary fibroblasts and neurons …

[HTML][HTML] SARS-CoV-2 vaccination and the multi-hit hypothesis of oncogenesis

RV Angues, YP Bustos - Cureus, 2023 - ncbi.nlm.nih.gov
Cancer is a complex and dynamic disease. The “hallmarks of cancer” were proposed by
Hanahan and Weinberg (2000) as a group of biological competencies that human cells …

[HTML][HTML] The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma

M Sellin, S Berg, P Hagen, J Zhang - Translational Oncology, 2022 - Elsevier
Multiple myeloma (MM) treatment regimens have vastly improved since the introduction of
immunomodulators, proteasome inhibitors, and anti-CD38 monoclonal antibodies; however …

[HTML][HTML] An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis

UA Awan, AA Khattak, N Ahmed, X Guo… - Frontiers in …, 2023 - frontiersin.org
Background Breast Cancer (BC) stands out as the widely prevalent malignancy among all
the types of cancer affecting women worldwide. There is significant evidence that the …

The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer

M Russi, D Marson, A Fermeglia, S Aulic… - Pharmacology & …, 2022 - Elsevier
The breast cancer type 1 susceptibility protein (BRCA1) and its partner–the BRCA1-
associated RING domain protein 1 (BARD1)–are key players in a plethora of fundamental …

[HTML][HTML] Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors

X Xie, C Chen, C Wang, Y Guo, B Sun, J Tian, J Yan… - Redox Biology, 2024 - Elsevier
BRCA1 is one of the most frequently-mutated tumor suppressor genes in ovarian and breast
cancers. Loss of BRCA1 triggers homologous recombination (HR) repair deficiency …